What's on this Page
What is Raxibacumab
Raxibacumab is a human monoclonal antibody against Bacillus anthracis protective antigen for the treatment of inhalation anthrax.
It was developed for emergency use, and 20,000 doses of the drug were sent to the US Strategic National Stockpile in the first quarter of 2009.
Indications & Dosage
- anthrax
- anthrax prophylaxis
- Bacillus anthracis
Side Effects
- anemia
- back pain
- drowsiness
- erythema
- fatigue
- flushing
- hypertension
- infusion-related reactions
- insomnia
- leukopenia
- lymphadenopathy
- maculopapular rash
- palpitations
- peripheral edema
- pruritus
- rash
- seizures
- syncope
- urticaria
- vertigo
Monitoring Parameters
- laboratory monitoring not necessary
Contraindications
- breast-feeding
- infusion-related reactions
- pregnancy
Interactions
No information is available regarding drug interactions associated with Raxibacumab
